Poseida Therapeutics Announces Board Change

Eric Ostertag, M.D., Ph.D., Founder and current Executive Chairman, to retire from the Board of Directors and remain a consultant to the Company SAN DIEGO, Jan. 31, 2023 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks